SRPT Stock Sees Surge of Approximately 5.35% in Last Five Days
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sarepta Therapeutics
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sarepta Therapeutics
Sarepta Therapeutics Inc’s recent filing unveils that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Sarepta Therapeutics Inc revealed its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar
Sarepta Therapeutics Inc’s recent filing unveils that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Sarepta Therapeutics Inc’s filing revealed that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11